South Korea's Daewoong Pharmaceutical Co Ltd said on Tuesday it received Indian regulatory approval to test its antiparasitic niclosamide drug to treat COVID19 patients in an earlystage human trial. from Top Business News- News18.com Read The Rest:timesnownews...
No comments: